- JP-listed companies
- SUSMED, Inc.
- Cash flow
SUSMED, Inc. (4263) Cash flow
Market cap
¥11.9B
P/E ratio
-22x
Susmed develops digital therapeutic apps and IT platforms that help pharmaceutical companies and healthcare providers conduct clinical trials and analyze medical data more efficiently.
| 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | 2026/06 | |
| Depreciation & amortization | 0 | 0 | 2 | 6 | 6 | 8 | 10 |
| Cash from operations | -89 | -235 | -165 | 101 | -231 | -432 | -474 |
| Capital expenditures | -4 | -4 | -13 | -6 | -3 | -4 | -74 |
| Cash from investing | -6 | -4 | -20 | -18 | -9 | -20 | -228 |
| Repurchases of common stock | - | - | - | - | -0 | -0 | -0 |
| Cash from financing | - | 1,500 | 3,463 | 62 | 37 | 4 | 3 |